Stockscreener 앱 받기
1.9179
1.59%
0.0279
전일 마감가:
$1.89
열려 있는:
$1.98
하루 거래량:
264.41K
Relative Volume:
0.75
시가총액:
$47.78M
수익:
-
순이익/손실:
$-16.51M
주가수익비율:
-1.4177
EPS:
-1.3528
순현금흐름:
$-15.68M
1주 성능:
-5.88%
1개월 성능:
-12.73%
6개월 성능:
-26.15%
1년 성능:
-30.18%
1일 변동 폭
$1.90
$2.0317
1주일 범위
$1.87
$2.25
52주 변동 폭
$1.675
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
명칭
Medicus Pharma Ltd
전화
610-540-7515
주소
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
MDCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.9338 | 46.70M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,058.29 | 919.64B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
214.16 | 509.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.74 | 394.69B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
134.38 | 254.37B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
99.05 | 248.95B | 63.90B | 19.05B | 13.05B | 7.5596 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Medicus Pharma completes enrollment for Phase 2 basal cell carcinoma study - Proactive financial news
Medicus Pharma Completes Patient Enrollment for Phase 2 BCC Treatment Study - TipRanks
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Manila Times
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Greenville Online
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Norwich Bulletin
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 - Victorville Daily Press
Medicus Pharma’s Warrant Inducement Agreement Announced - TipRanks
Medicus Pharma Elevates President Carolyn Bonner to CFO as Clinical Pipeline Accelerates - MyChesCo
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Daytona Beach News-Journal
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Daytona Beach News-Journal
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Asheville Citizen Times
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing - The Times Telegram
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Daytona Beach News-Journal
Medicus Pharma secures $5.1 million from warrant exercise agreement By Investing.com - Investing.com Nigeria
Medicus Pharma secures $5.1 million from warrant exercise agreement - Investing.com India
Medicus Pharma Shakes Up Executive Ranks as President Takes on CFO Role - MSN
How Medicus Pharma Ltd. stock reacts to oil prices2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
How Medicus Pharma Ltd. Equity Warrant stock trades during market volatilityJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Is Medicus Pharma Ltd. Equity Warrant stock attractive for retirement portfoliosTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
Medicus Pharma appoints Carolyn Bonner as CFO - Pharmafile
How currency fluctuations impact Medicus Pharma Ltd. stockJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials - MSN
Medicus Pharma promotes president to chief financial officer - Pennsylvania Business Report -
Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser
Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch - marketscreener.com
How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Setups & Safe Capital Allocation Plans - Newser
How big funds are accumulating Medicus Pharma Ltd. (N460) stockInsider Buying & Technical Confirmation Trade Alerts - Newser
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser
Medicus Pharma shares updates on basal cell carcinoma trials - Pharmafile
Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns By Investing.com - Investing.com Canada
Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation - Investing.com Australia
Medicus Pharma Ltd (MDCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.72%
1.91%
자본화:
|
볼륨(24시간):